CRISPR-Cas9编辑人类胚胎干细胞中的突触基因,用于诱导人类神经元中的功能分析

Aiden Houcek1, Z Zack Ma2, Brent Trauterman2

  • 1Department of Pharmacology, Vanderbilt University, Nashville, TN, USA; Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA; Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.

STAR protocols
|May 25, 2024
PubMed
概括

这项研究详细介绍了CRISPR-Cas9协议,用于制造具有特定基因突变的淘汰人类胚胎干细胞 (hESC),用于研究蛋白质功能和产生诱导神经元.